In silico evaluation of Benzo (f) chromen-3-one as a potential inhibitor of NF-κB: A key regulatory molecule in inflammation-mediated pathogenesis of diabetes, Alzheimer's, and cancer

2018 Journal of Applied Pharmaceutical Science  
doi:10.7324/japs.2018.81218 fatcat:5fw4ridfp5fyppopmpdckh6xce